Abstract
Phyllodes tumors (PT) are rare fibroepithelial lesions, about 0.3–0.5% of all breast tumors. This study is an evaluation of patient characteristics, clinicopathologic features, diagnostic tools, therapeutic options, risk factors for recurrence, and distant metastasis and follow-up findings in patients with PTs. One hundred twenty-seven patients with pathologically proved PTs in the National Cancer Institute, Cairo University, Egypt, from January 2011 to January 2016 were reviewed and analyzed. Sixty patients presented with benign PTs (47.2%), 34 had borderline PTs (26.8%), and 33 had malignant PTs (26%). The mean follow-up period was approximately 36 months; local recurrence occurred in 34 patients, 9 benign cases (14.5%), 11 borderlines (32.4%), and 14 malignant PTs (42.4%). Mastectomy was the most commonly used surgery in recurrent cases (61.4%). Axillary staging was performed in 31 cases (24.4%); only 2 cases showed positive nodal metastasis (6.5%) and were of the malignant subtype. Distant metastasis occurred in 12 patients, 4 with borderline PTs, and 8 with malignant PTs. The most common site for metastasis was the lungs and bones. Adjuvant radiotherapy was applied in 9 patients, 2 in borderline phyllodes, and 7 in malignant phyllodes; post-radiotherapy recurrence occurred in 5 malignant phyllodes patients. Chemotherapy was employed in 10 metastatic patients (4 with borderline and 6 with malignant phyllodes); excision with clear margins is important to reduce the local recurrence. Routine axillary staging should not be done. The adjuvant radiation therapy is still controversial. Local recurrence can develop even after appropriate surgery. Therefore, close follow-up is mandatory.
Similar content being viewed by others
References
Abdalla HM, Sakr MA (2006) Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Cancer Inst 18:125–133
Abdulcadir D, Nori J, Meattini I, Giannotti E, Boeri C, Vanzi E, Vezzosi V, Bianchi S (2014) Phyllodes tumors of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature. Eur J Surg Oncol 40:859–864
Acar T, Tarcan E, Hacıyanlı M, Kamer E, Peşkersoy M, Yiğit S, Gür Ö, Cin N, Sarı AA, Tatar F (2015) How to approach phyllodes tumors of the breast? Ulus Cerrahi Derg 31:197–201
Atalay C, Kınaş V, Çelebioğlu S (2014) Analysis of patients with phyllodes tumor of the breast. Ulus Cerrahi Derg 30:129–132
Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil S, van Zee KJ (2007) Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14:2961–2970
Barth RJ, Wells WA, Mitchell SE et al (2009) A prospective multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 16:2288–2294
Barth RJ, Richard J., Wells, et al. (2016) A Prospective, Multi-Institutional Study of Adjuvant Radiotherapy After Resection of Malignant Phyllodes Tumors. Pubmed central
Belkacemi Y, Bousquet G, Marsiglia H et al (2008) Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 70:492–500
Calhoun KE, Lawton J, Kim JN, C D et al (2010) Diseases of the breast. Lippincott Williams & Wilkins, Philadelphia, pp 781–792
Chaney AW, Pollack A, McNeese MD et al (2000) Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 89:1502–1511
Chao T, Lo Y, Chen S, Chen M (2003) Phyllodes tumors of the breast. Eur Radiol 13:88–93
Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA (2004) Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22:2303–2312
Confavreux C, Lurkina A, Mitton N et al (2006) Sarcomas and malignant phyllodes tumors of the breast – a retrospective study. Eur J Cancer 42:2715–2721
Gatta G, Iaselli F, Parlato V, di Grezia G, Grassi R, Rotondo A (2011) Differential diagnosis between fibroadenoma, giant fibroadenoma and phyllodes tumour: sonographic features and core needle biopsy. Radiol Med 116:905–918
Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA (2014) Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol 21:1222–1230
Jang JH, Choi M-Y, Lee SK, Kim S, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Cho EY, Lee JE, Nam SJ, Yang JH (2012) Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 19:2612–2617
Kim S, Kim J-Y, Kim DH, Jung WH, Koo JS (2013) Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat 141:353–363
Lakhani SR, Ellis IO, Schnitt SJ et al (2012) International Agency for Research on Cancer, World Health Organization. In: WHO classification of tumors of the breast, 4th edn. International Agency for Research on Cancer, Lyon, p 240
Lin C-C, Chang H-W, Lin C-Y, Chiu CF, Yeh SP (2013) The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan. Int J Clin Oncol 18:614–620
Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK (2006) Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the surveillance, epidemiology, and end results (SEER) program. Cancer. 107:2127–2133
Mallick S, Joshi NP, Roy S et al (2016) Malignant and borderline phyllodes tumor of breast treated with a multi-modality approach in a tertiary cancer care centre in North India South Asian. J Cancer 5(1):1–3
Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MJ, Souba WW (1999) Surgical management of phyllodes tumors. Arch Surg 134:487–492 discussion 492–493
McCarthy E, Kavanagh J, O’Donoghue Y et al (2014) Phyllodes tumors of the breast: radiological presentation, management and follow-up. Br J Radiol 87:20140239
Mishra SP, Tiwary SK, Mishra M et al (2013) Phyllodes tumor of breast: a review article. ISRN Surg:361–469
Mituś J, Reinfuss M, Mituś JW, Jakubowicz J, Blecharz P, Wysocki WM, Skotnicki P (2014) Malignant phyllodes tumor of the breast: treatment and prognosis. Breast J 20:639–644
Rosen PP (2001) Rosen’s breast pathology, 2nd edn, New York, Lippincott William Wikins
Salvadori B, Cusumano F, Del Bo R et al (1989) Surgical treatment of phyllodes tumors of the breast. Cancer 62:2532–2536
Santiago Chinchilla A, Ramos Font C, Custodio Rebollo Aguirre A et al (2010) Malignant phyllodes tumor of the breast with lymph node metastases shown by FDG PET-CT. Rev Esp Med Nucl 29:314–315
Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, Sangalli C, Catania C, Toffalorio F, Noberasco C, Delmonte A, Luini A, Veronesi P, Colleoni M, Viale G, Zurrida S, Goldhirsch A, Veronesi U, de Pas T (2013) Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol 88:427–436
Suzuki-Uematsu S, Shiraishi K, Ito T, Adachi N, Inage Y, Taeda Y, Ueki H, Ohtani H (2010) Malignant phyllodes tumor composed almost exclusively of a fibrosarcomatous component: a case report and review of malignant phyllodes tumors with metastases. Breast Cancer 17:218–224
Tan H, Zhang S, Liu H et al (2012a) Imaging findings in phyllodes tumors of the breast. Eur J Radiol 81:62–69
Tan PH, Thike AA, Tan WJ, Thu MMM, Busmanis I, Li HH, Chay WY, Tan MH, The Phyllodes Tumour Network Singapore (2012b) Predicting clinical behaviour of breast phyllodes tumors: a nomogram based on histological criteria and surgical margins. J Clin Pathol 65:69–76
Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V, Farshid G, Fox SB, Ichihara S, Lakhani SR, Rakha EA, Reis-Filho JS, Richardson AL, Sahin A, Schmitt FC, Schnitt SJ, Siziopikou KP, Soares FA, Tse GM, Vincent-Salomon A, Tan PH (2016) Phyllodes tumors of the breast: a consensus review. Histopathology. 68:5–21
Telli ML, Horst KC (2007) Phyllodes tumors of the breast: natural history, diagnosis and treatment. J Natl Compr Cancer Netw 5:324–330
Teo JY, Cheong CS-J, Wong CY (2012) Low local recurrence rates in young Asian patients with phyllodes tumors: less is more. ANZ J Surg 82:325–328
Testori A, Meroni S, Errico V, Travaglini R, Voulaz E, Alloisio M (2015) Huge malignant phyllodes breast tumor: a real entity in a new era of early breast cancer. World J Surg Oncol 13:81
Ward ST, Jewkes AJ, Jones BG, Chaudhri S, Hejmadi RK, Ismail T, Hallissey MT (2012) The sensitivity of needle core biopsy in combination with other investigations for the diagnosis of phyllodes tumors of the breast. Int J Surg 10:527–531
World Health Organization (1981) Histologic Typing of Breast Tumors, vol 2, 2nd edn. WHO, Geneva
Yom CK, Han W, Kim S-W, Park SY, Park IA, Noh DY (2015) Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast. Ann Surg Oncol 22:2912–2918
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ibreaheem, M.H., Naguib, S., Gamal, M. et al. Phyllodes Tumors of the Breast (the Egyptian Experience). Indian J Surg Oncol 11, 423–432 (2020). https://doi.org/10.1007/s13193-020-01107-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-020-01107-5